Atlas Trials

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension

Clinical trial NCT06282549 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06282549
Sponsor
Yuhan Corporation
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Essential Hypertension
Start date
2022-06-08
Primary completion
2027-03-31
Enrollment
1219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.